PL376122A1 - Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine - Google Patents

Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine

Info

Publication number
PL376122A1
PL376122A1 PL376122A PL37612205A PL376122A1 PL 376122 A1 PL376122 A1 PL 376122A1 PL 376122 A PL376122 A PL 376122A PL 37612205 A PL37612205 A PL 37612205A PL 376122 A1 PL376122 A1 PL 376122A1
Authority
PL
Poland
Prior art keywords
vaccine
manufacture
recombined
application
protein gene
Prior art date
Application number
PL376122A
Other languages
Polish (pl)
Other versions
PL205229B1 (en
Inventor
Andrzej Fitzner
Andrzej Kesy
Boguslaw Szewczyk
Beata Gromadzka
Original Assignee
Panstwowy Inst Weterynaryjny P
Univ Gdanski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panstwowy Inst Weterynaryjny P, Univ Gdanski filed Critical Panstwowy Inst Weterynaryjny P
Priority to PL376122A priority Critical patent/PL205229B1/en
Priority to PCT/PL2006/000047 priority patent/WO2007008093A2/en
Priority to EP06769511A priority patent/EP1904098A2/en
Publication of PL376122A1 publication Critical patent/PL376122A1/en
Publication of PL205229B1 publication Critical patent/PL205229B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL376122A 2005-07-08 2005-07-08 Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine PL205229B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL376122A PL205229B1 (en) 2005-07-08 2005-07-08 Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine
PCT/PL2006/000047 WO2007008093A2 (en) 2005-07-08 2006-07-06 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine
EP06769511A EP1904098A2 (en) 2005-07-08 2006-07-06 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL376122A PL205229B1 (en) 2005-07-08 2005-07-08 Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine

Publications (2)

Publication Number Publication Date
PL376122A1 true PL376122A1 (en) 2007-01-22
PL205229B1 PL205229B1 (en) 2010-03-31

Family

ID=37562591

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376122A PL205229B1 (en) 2005-07-08 2005-07-08 Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine

Country Status (3)

Country Link
EP (1) EP1904098A2 (en)
PL (1) PL205229B1 (en)
WO (1) WO2007008093A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019195938A1 (en) * 2018-04-11 2019-10-17 Luminultra Technologies Ltd. Methods and kits for nucleic acid purification and other procedures
CN112480269A (en) * 2020-12-11 2021-03-12 杭州爱谨生物科技有限公司 Rabbit viral hemorrhagic disease virus VP10-VP60 recombinant protein and preparation method and application thereof
WO2023014983A2 (en) * 2021-08-05 2023-02-09 VST LLC dba Medgene Labs Rabbit haemorrhagic disease virus (rhdv) vaccines
CN115444933B (en) * 2022-09-14 2023-08-29 贵州福斯特生物科技有限公司 Preparation method and application of a water-soluble compound adjuvant for rabbits

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080023B1 (en) * 1994-07-08 1996-08-16 Iberica Cyanamid RECOMBINANT CAPSIDS AND PROTEINS FROM RABBIT BLEEDING DISEASE VIRUS (RHDV), DIAGNOSTIC KITS AND VACCINES CONTAINING SUCH RECOMBINANT PRODUCTS.

Also Published As

Publication number Publication date
WO2007008093A2 (en) 2007-01-18
PL205229B1 (en) 2010-03-31
WO2007008093A3 (en) 2007-04-19
EP1904098A2 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
EG25848A (en) Systems and methods for protein production
ZA200703561B (en) Methods and compositions for improving recombinant protein production
IL179140A0 (en) Antibody drug conjuates and methods
PL1971366T3 (en) Human IL-23 Antibodies, Compositions, Methods, and Use
EP1856291A4 (en) Nucleic acids and proteins and methods for making and using them
EP1912667A4 (en) Concentrated protein lyophilates, methods, and uses
IL182837A0 (en) Methods, assays and compositions for treating retinol-related diseases
SG10201600950TA (en) Recombinant monovalent antibodies and methods for production thereof
IL181278A0 (en) Systems and methods for protein production
EP1901820A4 (en) Method for reducing levels of disease associated proteins
DK1768833T3 (en) Form body, process for its preparation and its use
EP1766073A4 (en) Enhancing protein expression
EP1922086A4 (en) Targeted protein kinase c inhibitors and uses thereof
EP1731139A4 (en) S/o type pharmaceutical preparation and process for producing the same
PL376122A1 (en) Method for the manufacture of recombined vaccine for the rabbit haemorrhagic disease, vaccine and application of recombined protein gene in manufacture of the vaccine
EP1757303A4 (en) Human lysozyme medicine, its manufacturing method and application thereof
EP1805210A4 (en) Novel peptides and methods for the treatment of inflammatory disease
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
EP1922328A4 (en) Peptides targeted to protein kinase c isoforms and uses thereof
ZA200804337B (en) Recombinant monovalent antibodies and methods for production thereof
EP1760149A4 (en) Method of constructing modified protein
ITPD20050075A1 (en) PROCEDURE FOR THE CONSTRUCTION OF DECORATIONS AT LEAST PART BISPECCHIATI AND PRODUCT OBTAINED
EP1881843A4 (en) Kinase peptides and antibodies
GB0404929D0 (en) Protein
GB0401882D0 (en) Protein